The Australian operations are already priced in. The longer we go without any confirmed contracts in Asia, the more the stock will drift.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025